cytidine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, S; Gu, Y; Li, G; Liu, H; Pang, D; Wang, J; Yang, Z; Zeng, J; Zhang, X | 1 |
1 other study(ies) available for cytidine and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Revealing the Potential Markers of N(4)-Acetylcytidine through acRIP-seq in Triple-Negative Breast Cancer.
Topics: Cytidine; Humans; Prognosis; RNA, Long Noncoding; Triple Negative Breast Neoplasms | 2022 |